These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10203039)

  • 21. CD4(+) T helper cells and the role they play in viral control.
    Norris PJ; Rosenberg ES
    J Mol Med (Berl); 2002 Jul; 80(7):397-405. PubMed ID: 12110945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.
    Seth N; Kaufmann D; Lahey T; Rosenberg ES; Wucherpfennig KW
    J Immunol; 2005 Nov; 175(10):6948-58. PubMed ID: 16272355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.
    Blankson JN; Siliciano RF
    J Clin Invest; 2001 Mar; 107(5):549-51. PubMed ID: 11238554
    [No Abstract]   [Full Text] [Related]  

  • 24. Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.
    Boritz E; Palmer BE; Livingston B; Sette A; Wilson CC
    J Immunol; 2003 Jan; 170(2):1106-16. PubMed ID: 12517980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.
    Blazevic V; Sahgal N; Kessler HA; Landay AL; Shearer GM
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1887-93. PubMed ID: 11118074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
    Palmer BE; Boritz E; Blyveis N; Wilson CC
    J Virol; 2002 Jun; 76(12):5925-36. PubMed ID: 12021325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
    Tilton JC; Luskin MR; Johnson AJ; Manion M; Hallahan CW; Metcalf JA; McLaughlin M; Davey RT; Connors M
    J Virol; 2007 Mar; 81(6):2713-25. PubMed ID: 17182676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.
    Johnson S; Eller M; Teigler JE; Maloveste SM; Schultz BT; Soghoian DZ; Lu R; Oster AF; Chenine AL; Alter G; Dittmer U; Marovich M; Robb ML; Michael NL; Bolton D; Streeck H
    J Virol; 2015 Aug; 89(15):7494-505. PubMed ID: 25972560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed differentiation of potent effector CD8
    Takata H; Buranapraditkun S; Kessing C; Fletcher JL; Muir R; Tardif V; Cartwright P; Vandergeeten C; Bakeman W; Nichols CN; Pinyakorn S; Hansasuta P; Kroon E; Chalermchai T; O'Connell R; Kim J; Phanuphak N; Robb ML; Michael NL; Chomont N; Haddad EK; Ananworanich J; Trautmann L;
    Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
    Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
    Scriba TJ; Zhang HT; Brown HL; Oxenius A; Tamm N; Fidler S; Fox J; Weber JN; Klenerman P; Day CL; Lucas M; Phillips RE
    J Clin Invest; 2005 Feb; 115(2):443-50. PubMed ID: 15668739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS.
    Heeney J; Bogers W; Buijs L; Dubbes R; ten Haaft P; Koornstra W; Niphuis H; Nara P; Teeuwsen V
    Immunol Lett; 1996 Jun; 51(1-2):45-52. PubMed ID: 8811344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of virus-specific immune responses in SHIV(KU)-infected macaques treated with PMPA.
    Kumar A; Buch S; Foresman L; Bischofberger N; Lifson JD; Narayan O
    Virology; 2001 Jan; 279(1):97-108. PubMed ID: 11145893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hypothesis to explain the role of the suppressor and helper T cells in the immunologic selection of highly related human immunodeficiency virus isolates found in infected patients.
    Barnett E; Barnett N
    Med Hypotheses; 1997 Jul; 49(1):77-9. PubMed ID: 9247912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection.
    Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A
    AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals.
    Calarota SA; Foli A; Maserati R; Baldanti F; Paolucci S; Young MA; Tsoukas CM; Lisziewicz J; Lori F
    J Immunol; 2008 May; 180(9):5907-15. PubMed ID: 18424710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
    Karlsson AC; Younger SR; Martin JN; Grossman Z; Sinclair E; Hunt PW; Hagos E; Nixon DF; Deeks SG
    AIDS; 2004 Apr; 18(7):981-9. PubMed ID: 15096800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.
    Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD
    J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.